Brain Transport Profiles of Ginsenoside Rb1 by Glucose Transporter 1: In Vitro and in Vivo

Ginsenoside Rb1 (Rb1) has been demonstrated its protection for central nervous system and is apparently highly distributed to the brain. The objective of this study was to characterize Rb1 transport at the blood–brain barrier (BBB) using primary cultured rat brain microvascular endothelial cells (rB...

Full description

Bibliographic Details
Main Authors: Yu-Zhu Wang, Qing Xu, Wei Wu, Ying Liu, Ying Jiang, Qing-Qing Cai, Qian-Zhou Lv, Xiao-Yu Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-04-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fphar.2018.00398/full
id doaj-0595a3e40aca48f083a0bbdc69c90804
record_format Article
spelling doaj-0595a3e40aca48f083a0bbdc69c908042020-11-24T22:08:56ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122018-04-01910.3389/fphar.2018.00398344147Brain Transport Profiles of Ginsenoside Rb1 by Glucose Transporter 1: In Vitro and in VivoYu-Zhu WangQing XuWei WuYing LiuYing JiangQing-Qing CaiQian-Zhou LvXiao-Yu LiGinsenoside Rb1 (Rb1) has been demonstrated its protection for central nervous system and is apparently highly distributed to the brain. The objective of this study was to characterize Rb1 transport at the blood–brain barrier (BBB) using primary cultured rat brain microvascular endothelial cells (rBMEC), an in vitro BBB model. The initial uptake velocity of Rb1 in rBMEC was temperature- and concentration-dependent, and was significantly reduced by phloretin, an inhibitor of GLUT1 transporter, but was independent of metabolic inhibitor. Furthermore, the transport of Rb1 into rBMEC was significantly diminished in the presence of natural substrate α-D-glucose, suggesting a facilitated transport of Rb1 via GLUT1 transporter. The impact of GLUT1 on the distribution of Rb1 between brain and plasma was studied experimentally in rats. Administration of phloretin (5 mg/kg, i.v.) to normal rats for consecutive 1 week before Rb1 (10 mg/kg, i.v.) at 0.5, 2, and 6 h did not alter Rb1 concentrations in plasma, but resulted in significant decreased brain concentrations of Rb1 compared to in the phloretin-untreated normal rats (489.6 ± 58.3 versus 105.1 ± 15.1 ng/g, 193.8 ± 11.1 versus 84.8 ± 4.1 ng/g, and 114.2 ± 24.0 versus 39.9 ± 4.9 ng/g, respectively). The expression of GLUT1 in the phloretin-treated group by western blotting analysis in vitro and in vivo experiments was significantly decreased, indicating that the decreased transport of Rb1 in brain was well related to the down-regulated function and level of GLUT1. Therefore, our in vitro and in vivo results indicate that the transport of Rb1 at the BBB is at least partly mediated by GLUT1 transporter.http://journal.frontiersin.org/article/10.3389/fphar.2018.00398/fullcarrier-mediated transporterdrug transportblood–brain barrierglucose transporter 1ginsenoside Rb1
collection DOAJ
language English
format Article
sources DOAJ
author Yu-Zhu Wang
Qing Xu
Wei Wu
Ying Liu
Ying Jiang
Qing-Qing Cai
Qian-Zhou Lv
Xiao-Yu Li
spellingShingle Yu-Zhu Wang
Qing Xu
Wei Wu
Ying Liu
Ying Jiang
Qing-Qing Cai
Qian-Zhou Lv
Xiao-Yu Li
Brain Transport Profiles of Ginsenoside Rb1 by Glucose Transporter 1: In Vitro and in Vivo
Frontiers in Pharmacology
carrier-mediated transporter
drug transport
blood–brain barrier
glucose transporter 1
ginsenoside Rb1
author_facet Yu-Zhu Wang
Qing Xu
Wei Wu
Ying Liu
Ying Jiang
Qing-Qing Cai
Qian-Zhou Lv
Xiao-Yu Li
author_sort Yu-Zhu Wang
title Brain Transport Profiles of Ginsenoside Rb1 by Glucose Transporter 1: In Vitro and in Vivo
title_short Brain Transport Profiles of Ginsenoside Rb1 by Glucose Transporter 1: In Vitro and in Vivo
title_full Brain Transport Profiles of Ginsenoside Rb1 by Glucose Transporter 1: In Vitro and in Vivo
title_fullStr Brain Transport Profiles of Ginsenoside Rb1 by Glucose Transporter 1: In Vitro and in Vivo
title_full_unstemmed Brain Transport Profiles of Ginsenoside Rb1 by Glucose Transporter 1: In Vitro and in Vivo
title_sort brain transport profiles of ginsenoside rb1 by glucose transporter 1: in vitro and in vivo
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2018-04-01
description Ginsenoside Rb1 (Rb1) has been demonstrated its protection for central nervous system and is apparently highly distributed to the brain. The objective of this study was to characterize Rb1 transport at the blood–brain barrier (BBB) using primary cultured rat brain microvascular endothelial cells (rBMEC), an in vitro BBB model. The initial uptake velocity of Rb1 in rBMEC was temperature- and concentration-dependent, and was significantly reduced by phloretin, an inhibitor of GLUT1 transporter, but was independent of metabolic inhibitor. Furthermore, the transport of Rb1 into rBMEC was significantly diminished in the presence of natural substrate α-D-glucose, suggesting a facilitated transport of Rb1 via GLUT1 transporter. The impact of GLUT1 on the distribution of Rb1 between brain and plasma was studied experimentally in rats. Administration of phloretin (5 mg/kg, i.v.) to normal rats for consecutive 1 week before Rb1 (10 mg/kg, i.v.) at 0.5, 2, and 6 h did not alter Rb1 concentrations in plasma, but resulted in significant decreased brain concentrations of Rb1 compared to in the phloretin-untreated normal rats (489.6 ± 58.3 versus 105.1 ± 15.1 ng/g, 193.8 ± 11.1 versus 84.8 ± 4.1 ng/g, and 114.2 ± 24.0 versus 39.9 ± 4.9 ng/g, respectively). The expression of GLUT1 in the phloretin-treated group by western blotting analysis in vitro and in vivo experiments was significantly decreased, indicating that the decreased transport of Rb1 in brain was well related to the down-regulated function and level of GLUT1. Therefore, our in vitro and in vivo results indicate that the transport of Rb1 at the BBB is at least partly mediated by GLUT1 transporter.
topic carrier-mediated transporter
drug transport
blood–brain barrier
glucose transporter 1
ginsenoside Rb1
url http://journal.frontiersin.org/article/10.3389/fphar.2018.00398/full
work_keys_str_mv AT yuzhuwang braintransportprofilesofginsenosiderb1byglucosetransporter1invitroandinvivo
AT qingxu braintransportprofilesofginsenosiderb1byglucosetransporter1invitroandinvivo
AT weiwu braintransportprofilesofginsenosiderb1byglucosetransporter1invitroandinvivo
AT yingliu braintransportprofilesofginsenosiderb1byglucosetransporter1invitroandinvivo
AT yingjiang braintransportprofilesofginsenosiderb1byglucosetransporter1invitroandinvivo
AT qingqingcai braintransportprofilesofginsenosiderb1byglucosetransporter1invitroandinvivo
AT qianzhoulv braintransportprofilesofginsenosiderb1byglucosetransporter1invitroandinvivo
AT xiaoyuli braintransportprofilesofginsenosiderb1byglucosetransporter1invitroandinvivo
_version_ 1725813749052342272